tomeko

Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus

Just diagnosed with Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus, look for clinical trials, and connect with others living with it — all in one place.

Open the full Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus hub →

Overview

Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus is a rare condition. Also known as Furukawa-Takagi-Nakao syndrome. Tomeko brings together the specialists, research, clinical trials, treatments and community for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:2579 · OMIM 158500 · ICD-10 G11.1 · GARD 0002417

Find care for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus

Authoritative references for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus

Common questions

I was just diagnosed with Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus, filtered to your area.

Are there clinical trials for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus?

Tomeko shows live, recruiting studies for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com